CareDx, Inc.

CDNA US14167L1035

🆔
Registration No.
2982485
💰
Capitalization
Small-cap

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

🔗
Website
Annual Performance 1
2021 2022 2023 2024 2025
-36% -76% 8% 79% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
38
🙍
Insiders
8
Person Price Shares Total Published Completed
Novack Jeffrey Adam
SEC 		12.79
USD 		2,688
Sold 		34,381
USD 		05/08/2025 05/08/2025
Maag Peter
O 		18.58
USD 		10,000
Sold 		185,831
USD 		07/07/2025 07/07/2025
Maag Peter
O 		18.58
USD 		10,000
Sold 		185,831
USD 		07/07/2025 07/07/2025
Valantine Hannah
 19.16
USD 		10,570
Sold 		202,566
USD 		18/06/2025 18/06/2025
Maag Peter
 19.24
USD 		10,000
Sold 		192,420
USD 		17/06/2025 17/06/2025
Maag Peter
 19.24
USD 		10,000
Sold 		192,420
USD 		17/06/2025 17/06/2025
Maag Peter
 19.24
USD 		10,000
Sold 		192,420
USD 		17/06/2025 17/06/2025
Hagstrom William A
 19.90
USD 		19,391
Sold 		385,918
USD 		11/06/2025 11/06/2025
Hagstrom William A
 19.90
USD 		19,391
Sold 		385,918
USD 		11/06/2025 11/06/2025
Hagstrom William A
 17.45
USD 		30,000
Sold 		523,413
USD 		28/05/2025 28/05/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include CareDx, Inc. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-30% 18% 82% 156% -40% 896% 241%
Last 52W Low 52W High All-Time Low All-Time High β
14.96 11.57 20.63 11.57 20.63
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Johnson Alexander L 5 3,159,749.13 631,949.83 19/08/2024 21/08/2024
Maag Peter 11 2,706,006.22 246,000.57 20/08/2024 07/07/2025
Hagstrom William A 4 1,818,661.48 454,665.37 28/05/2025 11/06/2025
Cournoyer Christine 4 1,401,902.92 350,475.73 06/05/2025 12/05/2025
Novack Jeffrey Adam 11 411,281.14 37,389.19 18/11/2024 05/08/2025
Bickerstaff George 1 367,102.00 367,102.00 10/03/2025 10/03/2025
Valantine Hannah 1 202,565.59 202,565.59 18/06/2025 18/06/2025
Jain Abhishek 1 4,695.80 4,695.80 07/04/2025 07/04/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.